Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

NCT07058025 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia (BPD)
ELGAN (22-28SA)

Interventions

BIOLOGICAL: Human Allogenic Umbilical Cord Mesenchymal Stromal Cells
OTHER: Sham procedure control

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]
[object Object]